176 related articles for article (PubMed ID: 9442163)
1. First trimester sonographic detection of chromosomal abnormalities in an unselected population.
Economides DL; Whitlow BJ; Kadir R; Lazanakis M; Verdin SM
Br J Obstet Gynaecol; 1998 Jan; 105(1):58-62. PubMed ID: 9442163
[TBL] [Abstract][Full Text] [Related]
2. The value of sonography in early pregnancy for the detection of fetal abnormalities in an unselected population.
Whitlow BJ; Chatzipapas IK; Lazanakis ML; Kadir RA; Economides DL
Br J Obstet Gynaecol; 1999 Sep; 106(9):929-36. PubMed ID: 10492104
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of fetal nuchal translucency.
Jackson M; Rose NC
Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
[TBL] [Abstract][Full Text] [Related]
4. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
[TBL] [Abstract][Full Text] [Related]
6. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
Josefsson A; Molander E; Selbing A
Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
[TBL] [Abstract][Full Text] [Related]
7. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
Chasen ST; Sharma G; Kalish RB; Chervenak FA
Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
[TBL] [Abstract][Full Text] [Related]
8. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
Snijders RJ; Noble P; Sebire N; Souka A; Nicolaides KH
Lancet; 1998 Aug; 352(9125):343-6. PubMed ID: 9717920
[TBL] [Abstract][Full Text] [Related]
9. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
Nicolaides KH; Azar G; Byrne D; Mansur C; Marks K
BMJ; 1992 Apr; 304(6831):867-9. PubMed ID: 1392745
[TBL] [Abstract][Full Text] [Related]
10. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
11. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia.
Sebire NJ; Snijders RJ; Davenport M; Greenough A; Nicolaides KH
Obstet Gynecol; 1997 Dec; 90(6):943-6. PubMed ID: 9397108
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening.
Cheng CC; Bahado-Singh RO; Chen SC; Tsai MS
Int J Gynaecol Obstet; 2004 Jan; 84(1):5-9. PubMed ID: 14698823
[TBL] [Abstract][Full Text] [Related]
13. The optimal gestational age to examine fetal anatomy and measure nuchal translucency in the first trimester.
Whitlow BJ; Economides DL
Ultrasound Obstet Gynecol; 1998 Apr; 11(4):258-61. PubMed ID: 9618848
[TBL] [Abstract][Full Text] [Related]
14. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
Hafner E; Schuchter K; Philipp K
Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
[TBL] [Abstract][Full Text] [Related]
15. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.
Nicolaides KH
Am J Obstet Gynecol; 2004 Jul; 191(1):45-67. PubMed ID: 15295343
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
Theodoropoulos P; Lolis D; Papageorgiou C; Papaioannou S; Plachouras N; Makrydimas G
Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014
[TBL] [Abstract][Full Text] [Related]
18. [Pregnancy outcome in fetuses with increased nuchal translucency thickness at 10-14 weeks of pregnancy].
Maymon R; Dreazen E; Tovbin Y; Weinraub Z; Herman A
Harefuah; 1999 Jun; 136(11):851-5, 916, 915. PubMed ID: 10955127
[TBL] [Abstract][Full Text] [Related]
19. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
20. The 'Mickey Mouse' sign and the diagnosis of anencephaly in early pregnancy.
Chatzipapas IK; Whitlow BJ; Economides DL
Ultrasound Obstet Gynecol; 1999 Mar; 13(3):196-9. PubMed ID: 10204212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
